Opus Genetics, Inc. Shares Outstanding (Cover Page)
Opus Genetics, Inc. (IRD) had Shares Outstanding (Cover Page) of 83.20 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 83.20M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 81.40M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 71.15M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 68.96M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 83.20M shares 10-Q · filed 2026-08-06 |
| 2026-05-07 | 81.40M shares 10-Q · filed 2026-05-12 |
| 2026-03-05 | 71.15M shares 10-K · filed 2026-03-12 |
| 2025-11-10 | 68.96M shares 10-Q · filed 2025-11-12 |
| 2025-08-10 | 59.91M shares 10-Q · filed 2025-08-13 |
| 2025-05-12 | 59.66M shares 10-Q · filed 2025-05-15 |
| 2025-03-27 | 45.48M shares 10-K · filed 2025-03-31 |
| 2024-11-07 | 31.57M shares 10-Q · filed 2024-11-12 |
| 2024-08-09 | 26.20M shares 10-Q · filed 2024-08-13 |
| 2024-05-08 | 25.92M shares 10-Q · filed 2024-05-10 |
| 2024-03-05 | 24.81M shares 10-K · filed 2024-03-08 |
| 2023-11-07 | 22.64M shares 10-Q · filed 2023-11-13 |
| 2023-08-09 | 21.01M shares 10-Q · filed 2023-08-11 |
| 2023-05-10 | 20.95M shares 10-Q · filed 2023-05-15 |
| 2023-03-27 | 20.95M shares 10-K · filed 2023-03-30 |
| 2022-11-02 | 20.81M shares 10-Q · filed 2022-11-04 |
| 2022-08-09 | 20.58M shares 10-Q · filed 2022-08-12 |
| 2022-05-11 | 19.36M shares 10-Q · filed 2022-05-13 |
| 2022-03-23 | 18.99M shares 10-K · filed 2022-03-24 |
| 2021-11-10 | 17.30M shares 10-Q · filed 2021-11-12 |
| 2021-08-10 | 16.90M shares 10-Q · filed 2021-08-12 |
| 2021-05-05 | 12.56M shares 10-Q · filed 2021-05-07 |
| 2021-03-07 | 10.93M shares 10-K · filed 2021-03-11 |
| 2020-10-29 | 4.48M shares 10-Q · filed 2020-10-29 |
| 2020-08-14 | 4.23M shares 10-Q · filed 2020-08-14 |
| 2020-05-07 | 4.02M shares 10-Q · filed 2020-05-07 |
| 2020-02-21 | 4.02M shares 10-K · filed 2020-02-21 |
| 2019-11-06 | 4.02M shares 10-Q · filed 2019-11-06 |
| 2019-08-07 | 4.02M shares 10-Q · filed 2019-08-07 |
| 2019-05-10 | 4.02M shares 10-Q · filed 2019-05-10 |
| 2019-03-07 | 48.28M shares 10-K · filed 2019-03-07 |
| 2018-11-02 | 37.52M shares 10-Q · filed 2018-11-02 |
| 2018-08-03 | 31.75M shares 10-Q · filed 2018-08-03 |
| 2018-05-04 | 31.74M shares 10-Q · filed 2018-05-04 |
| 2018-03-09 | 31.74M shares 10-K · filed 2018-03-09 |
| 2017-11-03 | 31.73M shares 10-Q · filed 2017-11-03 |
| 2017-08-04 | 28.46M shares 10-Q · filed 2017-08-04 |
| 2017-05-03 | 254.22M shares 10-Q · filed 2017-05-03 |
| 2017-02-24 | 237.44M shares 10-K · filed 2017-02-24 |
| 2016-11-04 | 237.37M shares 10-Q · filed 2016-11-04 |
| 2016-08-05 | 213.31M shares 10-Q · filed 2016-08-05 |
| 2016-05-06 | 213.17M shares 10-Q · filed 2016-05-06 |
| 2016-03-11 | 213.11M shares 10-K · filed 2016-03-14 |
| 2015-11-02 | 180.75M shares 10-Q · filed 2015-11-02 |
| 2015-08-07 | 180.70M shares 10-Q · filed 2015-08-07 |
| 2015-05-08 | 179.57M shares 10-Q · filed 2015-05-08 |
| 2015-03-16 | 179.21M shares 10-K · filed 2015-03-16 |
| 2014-11-12 | 178.25M shares 10-Q · filed 2014-11-12 |
| 2014-08-13 | 178.25M shares 10-Q · filed 2014-08-13 |
| 2014-05-14 | 178.00M shares 10-Q · filed 2014-05-14 |
| 2014-03-21 | 176.53M shares 10-K · filed 2014-03-21 |
| 2013-11-13 | 146.72M shares 10-Q · filed 2013-11-13 |
| 2013-08-12 | 134.22M shares 10-Q · filed 2013-08-12 |
| 2013-05-09 | 119.43M shares 10-Q · filed 2013-05-09 |
| 2013-03-22 | 119.43M shares 10-K · filed 2013-03-22 |
| 2012-11-08 | 95.35M shares 10-Q · filed 2012-11-08 |
| 2012-08-08 | 95.35M shares 10-Q · filed 2012-08-08 |
| 2012-05-09 | 95.35M shares 10-Q · filed 2012-05-09 |
| 2012-03-15 | 95.35M shares 10-K · filed 2012-03-16 |
| 2011-11-09 | 95.35M shares 10-Q · filed 2011-11-09 |
| 2011-08-09 | 95.24M shares 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |